Myriad Genetics Data Breach Lawsuit Investigation

Shamis & Gentile P.A., one of the nation's premier class action law firms specializing in data breach cases, is investigating the Myriad Genetics, Inc. data breach.
If you were affected by the data breach, your sensitive personally identifiable information may have been exposed, and you may be eligible for compensation.
About Myriad Genetics
Myriad Genetics Inc. is a biotechnology company based in Salt Lake City, Utah. Founded in 1991, Myriad Genetics focuses on genetic testing and precision medicine, offering molecular diagnostic tests that help assess disease risk and guide treatment decisions.
What Happened?
On Nov. 2, 2026, Myriad Genetics detected unauthorized access within its information technology network environment.
After discovering the incident, the company initiated incident response procedures, including suspending some testing operations, alerting government systems and notifying certain customers. The company also engaged external experts to help investigate the breach and determine the full scope of the unauthorized access.
The investigation is ongoing, and as of the date of the disclosure, it was not yet clear if patient records or personal information were accessed. However, the company reported the incident to the U.S. Securities and Exchange Commission and stated that most of its systems remained operational.
You May Be Entitled to Compensation
If you were affected by the Myriad Genetics data breach, you may be eligible to join a class action lawsuit and receive compensation. Lawyers are actively investigating claims related to this incident. To find out if you qualify and to take the next step, complete the below form to join the lawsuit.
.png)